ArticleFrontiers in endocrinology2026
Analysis of metabolites in serum and villous tissue of missed abortion patients based on targeted metabolomics.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: In recent years, advancements in metabolomics have highlighted that changes in metabolic states within the body might also be closely related to missed abortion. However, the specific impacts of metabolic abnormalities on missed abortion remain unclear. This study screened differential metabolites in serum and villous tissues from patients with missed abortion, analyzed possible mechanisms linking metabolic disturbances to disease occurrence, and explored their clinical research value in early pregnancy abnormality research. Methods: Focusing on the effect of abnormal levels of metabolites on missed abortion, a prospective case-control study was conducted including 78 women with missed abortion and 75 women with normal early pregnancy undergoing elective termination. Targeted metabolomics profiling of serum and villous tissues was performed using mass spectrometry. Clinical characteristics and metabolite levels were compared between groups. Firth's logistic regression was applied to assess independent associations. ROC curve analysis was used to evaluate the discriminatory potential of key metabolites. Results: Results revealed metabolic differences in both serum and villous tissues between the missed abortion and control groups. Serum was characterized by upregulated amino acid metabolism, with elevated levels of multiple amino acids including ORN and TYR, which were associated with the risk of missed abortion. Villous tissues exhibited core disturbances in acylcarnitine metabolism, with C10:1 and C18 significantly upregulated in the missed abortion group. Notably, no highly consistent differential metabolites were identified between serum and villous tissues. Conclusion: This study demonstrates distinct metabolic signatures in missed abortion, with amino acid upregulation in serum and acylcarnitine disorder in villous tissues. Only CIT was consistently upregulated in both matrices, possibly due to limited assay coverage. Combined panels of the top eight FDR-ranked metabolites achieved high AUCs in serum and villous tissue, offering good auxiliary discrimination for missed abortion. These findings provide new insights into its metabolic pathogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.